HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The emerging role of anti-CD25 directed therapies as both immune modulators and targeted agents in cancer.

Abstract
CD25 (also termed IL2RA) forms one component of the high-affinity heterotrimeric interleukin 2 (IL2) receptor on activated T cells. Its affinity for IL2 and cellular function are tightly regulated and vary in different cell types. The high frequency of CD25 on the surface of many different haematological tumour cells is now well established and, apart from its prognostic significance, CD25 may be present on leukaemic stem cells and enable oncogenic signalling pathways in leukaemic cells. Additionally, high CD25 expression in activated circulating immune cells and Tregs is a factor that has already been exploited by IL2 immunotherapies for treatment of tumours and autoimmune disease. The relative clinical safety and efficacy of administering anti-CD25 radioimmunoconjugates and immunotoxins in various haematological tumour indications has been established and clinical trials of a novel CD25-directed antibody drug conjugate are underway.
AuthorsMichael J Flynn, John A Hartley
JournalBritish journal of haematology (Br J Haematol) Vol. 179 Issue 1 Pg. 20-35 (10 2017) ISSN: 1365-2141 [Electronic] England
PMID28556984 (Publication Type: Journal Article, Review)
Copyright© 2017 John Wiley & Sons Ltd.
Chemical References
  • Antibodies, Monoclonal
  • Immunologic Factors
  • Interleukin-2
  • Interleukin-2 Receptor alpha Subunit
  • Receptors, Interleukin-2
Topics
  • Antibodies, Monoclonal (pharmacology, therapeutic use)
  • Gene Expression Regulation (drug effects)
  • Humans
  • Immunologic Factors (pharmacology, therapeutic use)
  • Immunomodulation (drug effects)
  • Interleukin-2 (metabolism)
  • Interleukin-2 Receptor alpha Subunit (antagonists & inhibitors, genetics, immunology, metabolism)
  • Molecular Targeted Therapy
  • Neoplasms (drug therapy, genetics, immunology, metabolism)
  • Receptors, Interleukin-2 (metabolism)
  • Signal Transduction (drug effects)
  • T-Lymphocytes, Regulatory (drug effects, immunology, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: